Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NantWorks, LLC

http://www.nantworks.com

Latest From NantWorks, LLC

Keeping Track, Oncology Edition: Biologic Breakthroughs And BLAs

The latest oncology development news and highlights from our US FDA Performance Tracker.

US FDA Performance Tracker Cancer

Deal Watch: Celgene Joins Line Of Partners Tapping Exscientia’s AI-Driven Discovery Engine

While the proposed Bristol/Celgene merger nears an April vote, Celgene continues a recent spate of deal-making, paying $25m up front to Exscientia to discover small molecule candidates for cancer and autoimmune disease.

Business Strategies Commercial

Venture Funding Deals: Vedanta Raises More Cash To Advance Microbiome Candidates

Cancer drug-developer Black Diamond emerges from stealth mode with Series A and closes Series B in the same month, while aging-focused Juvenescence closes its initial tranche and looks complete Series B by the end of the quarter. 

Deals Financing

Celgene Settlement With Actavis Allows Abraxane Generics In 2022

Celgene settles Abraxane patent litigation and inter partes review with Teva's Actavis, allowing a generic to enter the market on March 31, 2022 – about four years before the drug's key patents expire.

Intellectual Property Legal Issues
See All

Company Information

  • Industry
  • Biotechnology
  • Diversified
  • In Vitro Diagnostics
  • Medical Devices
    • Monitoring Equipment & Devices
  • Other Names / Subsidiaries
    • Altor BioScience Corporation
    • Altor BioScience, LLC
    • IgDraSol, Inc.
    • ImmunityBio, Inc.
    • NantHealth
    • NantMobile
    • NantMedia
    • NantOmics
    • NantBioScience
    • NantCell, Inc.
    • NantPharma
    • NantCapital
    • NantCloud
UsernamePublicRestriction

Register